News

Deal Announcements

Arteriocyte Nets New Financing Of $10 Million

Monday, October 29, 2007 5:00:00 AM PDT | VentureDeal Staff
CLEVELAND, OH -- Biotechnology company Arteriocyte, Inc. has received $10 million in a new financing round, according to a report by VentureWire.

The company is developing proprietary, adult stem cell-based therapies focused on the treatment of ischemic diseases, which include coronary artery disease, peripheral vascular disease, vascular complications from diabetes and neurodegenerative conditions exacerbated by reduced blood flow.

DW Healthcare Partners and others invested in the round.  Proceeds purposes were not disclosed.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1